tert-butyl 4-bromo-2-fluorobenzoate

We are tert-butyl 4-bromo-2-fluorobenzoate CAS:889858-12-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:   tert-butyl 4-bromo-2-fluorobenzoate
CAS.NO:  889858-12-2
Synonyms:4-bromo-2-fluoro-benzoic acid tert-butyl ester
Tert-butyl 4-bromo-2-fluorobenzoate

Molecular Formula: C11H12BrFO2
Molecular Weight:275.11400

Physical and Chemical Properties:
Density: 1.394g/cm3
Boiling point: 281ºC at 760 mmHg
Melting point: /
Flash point: 123.7ºC
Refractive index: 1.515

Appearance:White  powder
A.H-NMR:Comply with the structure
B.LC-MS:Comply with the structure
C.The IR spectrum of sample should be identical with that of reference standard;
The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Loss on drying:≤0.5%
Heavy metals:≤10 ppm
Sulphated ash:≤0.2%, determined on 1.0 g.
Related substances:
Unspecified impurities: for each impurity:≤0.10%
Total Impurity:≤1.0%

 25kg 1 cardboard drum or according to customer specified requirements
Storage:Shade light and keep tightly closed.
Application: Intermediates of Enzalutamide CAS:915087-33-1.

 tert-butyl 4-bromo-2-fluorobenzoate

Related News: Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.1,2,3,4-Tetrafluorobenzene Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle – from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products.628-34-2 With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7-one CAS:1013916-37-4 “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.

Related Products
Product Name
Benzonitrile Cas:100-47-0 View Details
4-Chlorobutyryl chloride View Details
ethylene glycol monoethyl ether acetate Cas:111-15-9 View Details
Stigmasterol Cas:83-48-7 manufacturer 4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one manufacturer DIPHENYL AZIDOPHOSPHATE (DPPA) Cas:26386-88-9 manufacturer 2-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5,11-dimethylpyrimido[4,5-b][1,4]benzodiazepin-6-one Cas:1234480-84-2 manufacturer 1-(2-Furoyl)piperazine manufacturer